P.K. Epling-Burnette

569 total citations
26 papers, 412 citations indexed

About

P.K. Epling-Burnette is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, P.K. Epling-Burnette has authored 26 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 9 papers in Immunology and 6 papers in Genetics. Recurrent topics in P.K. Epling-Burnette's work include Acute Myeloid Leukemia Research (8 papers), Liver Disease Diagnosis and Treatment (5 papers) and Pancreatitis Pathology and Treatment (5 papers). P.K. Epling-Burnette is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Liver Disease Diagnosis and Treatment (5 papers) and Pancreatitis Pathology and Treatment (5 papers). P.K. Epling-Burnette collaborates with scholars based in United States, China and India. P.K. Epling-Burnette's co-authors include Julie Y. Djeu, Junmin Zhou, Jinfeng Wu, Xianghong Chen, Erika A. Eksioglu, Wei Sheng, Jingcheng Dong, Nicole Fortenbery, Krithika N. Kodumudi and JY Djeu and has published in prestigious journals such as Blood, Leukemia and Oncotarget.

In The Last Decade

P.K. Epling-Burnette

26 papers receiving 399 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P.K. Epling-Burnette United States 12 165 114 90 81 71 26 412
Mahdi Vojdanian Iran 13 113 0.7× 101 0.9× 52 0.6× 18 0.2× 26 0.4× 31 353
Sheng Yun China 11 199 1.2× 75 0.7× 36 0.4× 64 0.8× 16 0.2× 16 336
Yan Dai China 10 99 0.6× 182 1.6× 124 1.4× 52 0.6× 16 0.2× 19 421
Hideki Futamatsu Japan 10 187 1.1× 94 0.8× 79 0.9× 88 1.1× 11 0.2× 11 489
Powen Tu United States 6 106 0.6× 156 1.4× 62 0.7× 33 0.4× 7 0.1× 9 404
Jamie J.L. Williams United Kingdom 7 114 0.7× 177 1.6× 111 1.2× 34 0.4× 18 0.3× 8 344
Xiaofang Xiong China 12 201 1.2× 165 1.4× 98 1.1× 42 0.5× 7 0.1× 18 455
Yong‐Mei Guo Japan 11 120 0.7× 283 2.5× 52 0.6× 38 0.5× 15 0.2× 28 543
Janice M. Kraniak United States 11 84 0.5× 222 1.9× 104 1.2× 31 0.4× 31 0.4× 15 497
Aihiro Yamamoto Japan 11 211 1.3× 136 1.2× 51 0.6× 26 0.3× 8 0.1× 31 429

Countries citing papers authored by P.K. Epling-Burnette

Since Specialization
Citations

This map shows the geographic impact of P.K. Epling-Burnette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.K. Epling-Burnette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.K. Epling-Burnette more than expected).

Fields of papers citing papers by P.K. Epling-Burnette

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.K. Epling-Burnette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.K. Epling-Burnette. The network helps show where P.K. Epling-Burnette may publish in the future.

Co-authorship network of co-authors of P.K. Epling-Burnette

This figure shows the co-authorship network connecting the top 25 collaborators of P.K. Epling-Burnette. A scholar is included among the top collaborators of P.K. Epling-Burnette based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P.K. Epling-Burnette. P.K. Epling-Burnette is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ball, Markus, Yonggang Zhao, Maria E. Balasis, et al.. (2017). Intrapatient functional clonality deconvoluted by coupling intracellular flow cytometry and next-generation sequencing in human leukemia. Leukemia. 32(2). 532–538. 1 indexed citations
2.
McGraw, Kathy L., Jinming Song, David A. Sallman, et al.. (2016). EZH2 Protein Expression Is Decreased in MDS and MDS/MPN and Correlated with EZH2 Mutation Status, Chromosomal 7 Abnormalities and Clinical Outcome. Blood. 128(22). 4305–4305. 2 indexed citations
3.
Ding, Tingting, et al.. (2016). Effect of IL-7 and IL-15 on T cell phenotype in myelodysplastic syndromes. Oncotarget. 7(19). 27479–27488. 2 indexed citations
4.
Balasis, Maria E., Sateesh Kunigal, Yan Ma, et al.. (2015). Molecular Characterization of SRSF2 Mutation Identifies a Clinically Relevant Lncrna (MALAT1) in Chronic Myelomonocytic Leukemia (CMML). Blood. 126(23). 1641–1641. 1 indexed citations
5.
Liu, Yang, Adam W. Mailloux, Dana E. Rollison, et al.. (2012). Naive T-cells in myelodysplastic syndrome display intrinsic human telomerase reverse transcriptase (hTERT) deficiency. Leukemia. 27(4). 897–906. 17 indexed citations
6.
Zhou, Junmin, Jinfeng Wu, Xianghong Chen, et al.. (2011). Icariin and its derivative, ICT, exert anti-inflammatory, anti-tumor effects, and modulate myeloid derived suppressive cells (MDSCs) functions. International Immunopharmacology. 11(7). 890–898. 129 indexed citations
7.
Rollison, Dana E., P.K. Epling-Burnette, Jong Y. Park, et al.. (2011). Telomere length in myelodysplastic syndromes. Leukemia & lymphoma. 52(8). 1528–1536. 43 indexed citations
8.
Powers, John J., Eric Padron, Jason A. Dubovsky, et al.. (2011). Enhanced Immunological Responses Following K562/GM-CSF/CD40L Vaccine Plus Lenalidomide in High-Risk Myelodysplastic Syndrome. Blood. 118(21). 1725–1725. 2 indexed citations
9.
Komrokji, Rami S., et al.. (2011). 276 Outcome of azacitidine treatment of patients with therapy related myelodysplastic syndrome. Leukemia Research. 35. S108–S109. 1 indexed citations
10.
Sugimori, Chiharu, Kenneth H. Shain, Gisela Cáceres, et al.. (2010). Co-existence of JAK V617F and PIG-A mutations in primary Budd-Chiari syndrome. 1. 1 indexed citations
11.
Padron, Eric, Rami S. Komrokji, Jeffrey E. Lancet, et al.. (2010). A Phase I Pilot Study of Bystander Vaccine and Lenalidomide Immune Augmentation In Patients with Myelodysplastic Syndrome (MDS). Blood. 116(21). 2925–2925. 1 indexed citations
12.
Powers, John J., et al.. (2008). A Comprehensive Lymphocyte Analysis of Dasatinib Treated Chronic Myelogenous Leukemia Patients Reveals T-Cell Oligoclonality.. Blood. 112(11). 1114–1114. 2 indexed citations
13.
Gallagher, Scott F., Jun Yang, Krista Haines, et al.. (2004). Acute pancreatitis induces FasL gene expression and apoptosis in the liver1,2. Journal of Surgical Research. 122(2). 201–209. 22 indexed citations
14.
Yang, Jun, Scott F. Gallagher, Krista Haines, et al.. (2004). Kupffer cell–derived Fas Ligand plays a role in liver injury and hepatocyte death. Journal of Gastrointestinal Surgery. 8(2). 166–174. 28 indexed citations
15.
Yang, Jun, Yvette Carter, P.K. Epling-Burnette, et al.. (2003). Liver Injury During Acute Pancreatitis. Journal of Gastrointestinal Surgery. 7(2). 200–208. 28 indexed citations
16.
Epling-Burnette, P.K., Roy Garcia, Fanqi Bai, et al.. (2002). Carboxy-terminal truncated STAT5 is induced by interleukin-2 and GM-CSF in human neutrophils. Cellular Immunology. 217(1-2). 1–11. 12 indexed citations
17.
Murr, Michel M., et al.. (2002). Pancreatitis-Associated Ascitic Fluid Induces Hepatocyte Death Independent of Local Cytokines. Journal of Surgical Research. 106(2). 308–313. 16 indexed citations
18.
Wei, Sheng, Jin Hong Liu, P.K. Epling-Burnette, et al.. (2000). IL-2 Induces the Association of IL-2Rο, lyn, and MAP Kinase ERK-1 in Human Neutrophils. Immunobiology. 202(4). 363–382. 14 indexed citations
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mahdi Vojdanian Breakdown of academic impact, for papers by Sheng Yun Breakdown of academic impact, for papers by Yan Dai Breakdown of academic impact, for papers by Hideki Futamatsu Breakdown of academic impact, for papers by Powen Tu Breakdown of academic impact, for papers by Jamie J.L. Williams Breakdown of academic impact, for papers by Xiaofang Xiong Breakdown of academic impact, for papers by Yong‐Mei Guo Breakdown of academic impact, for papers by Janice M. Kraniak Breakdown of academic impact, for papers by Aihiro Yamamoto
Rankless by CCL
2026